What is Global Drug-Coated Balloons Market?
The Global Drug-Coated Balloons Market is a significant segment of the medical industry that focuses on the production and distribution of drug-coated balloons (DCBs). These specialized balloons are used in various medical procedures, particularly in the treatment of peripheral and coronary artery diseases. The coating on these balloons contains a drug that helps prevent the recurrence of arterial blockages, improving the overall effectiveness of the treatment. The market for these products is vast and global, encompassing manufacturers, healthcare providers, and patients across the world. The growth and development of this market are influenced by various factors, including advancements in medical technology, the prevalence of arterial diseases, and the increasing demand for effective and minimally invasive treatment options.
DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications in the Global Drug-Coated Balloons Market:
The Global Drug-Coated Balloons Market is segmented based on the specific medical indications for which these products are used. These include Peripheral Artery Disease (PAD), Coronary Artery Disease (CAD), and other indications. In the case of PAD, DCBs are used to treat blockages in the peripheral arteries, typically those in the legs. For CAD, DCBs are used to open up narrowed or blocked coronary arteries, improving blood flow to the heart. Other indications for DCBs include the treatment of in-stent restenosis and small vessel disease. Each of these segments has its unique market dynamics, influenced by factors such as the prevalence of the disease, the effectiveness of DCBs in treating it, and the availability and cost of alternative treatment options.
Hospitals, Cardiac Catheterization Labs, ASCs in the Global Drug-Coated Balloons Market:
The usage of DCBs in the Global Drug-Coated Balloons Market is also segmented based on the type of healthcare facilities where these products are used. These include hospitals, cardiac catheterization labs, and Ambulatory Surgical Centers (ASCs). In hospitals, DCBs are used in various surgical procedures, particularly those involving the treatment of arterial diseases. Cardiac catheterization labs, on the other hand, are specialized facilities where procedures involving the heart and blood vessels are performed, making them a significant user of DCBs. ASCs, which are healthcare facilities that provide surgical services on an outpatient basis, also use DCBs in their procedures. The usage of DCBs in these facilities is influenced by factors such as the volume of procedures performed, the availability of DCBs, and the preference of healthcare providers.
Global Drug-Coated Balloons Market Outlook:
Looking at the market outlook, the global pharmaceutical market, which includes the Global Drug-Coated Balloons Market, is projected to reach a value of 1475 billion USD in 2022. This represents a Compound Annual Growth Rate (CAGR) of 5% over the next six years. In comparison, the chemical drug market, a related but distinct segment of the pharmaceutical industry, is expected to grow from 1005 billion USD in 2018 to 1094 billion USD in 2022. These figures highlight the significant growth potential of the pharmaceutical industry, driven by factors such as advancements in medical technology, increasing healthcare expenditure, and the growing demand for effective and minimally invasive treatment options.
| Report Metric | Details |
| Report Name | Drug-Coated Balloons Market |
| CAGR | 5% |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Medtronic, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, BioMed, Concept Medical, Cardionovum, Endocor, Hexacath Sverige, iVascular SLU, Minvasys, MedAlliance, QT Vascular, RD Global-Invamed, SurModics, Terumo, Wellinq |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
